These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7739726)

  • 1. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.
    Colombo AL; McGough DA; Rinaldi MG
    Mycopathologia; 1994 Dec; 128(3):129-33. PubMed ID: 7739726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
    Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
    Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
    Moore CB; Law D; Denning DW
    J Antimicrob Chemother; 1993 Dec; 32(6):831-6. PubMed ID: 8144422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.
    Martinez J; Torres JM; Arteaga F; Foz-Tena A
    Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
    Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
    Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi.
    Kuzucu C; Rapino B; McDermott L; Hadley S
    J Clin Microbiol; 2004 Mar; 42(3):1224-7. PubMed ID: 15004080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R; Pina-Vaz C; Rodrigues AG
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods.
    Pfaller MA; Messer SA; Motyl MR; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1065-8. PubMed ID: 23229479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea.
    Heo MS; Shin JH; Choi MJ; Park YJ; Lee HS; Koo SH; Lee WG; Kim SH; Shin MG; Suh SP; Ryang DW
    Ann Lab Med; 2015 Nov; 35(6):602-10. PubMed ID: 26354348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
    Lass-Flörl C; Speth C; Kofler G; Dierch MP; Gunsilius E; Würzner R
    Int J Antimicrob Agents; 2003 Mar; 21(3):229-33. PubMed ID: 12636983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.
    Al-Saigh R; Siopi M; Siafakas N; Velegraki A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3713-8. PubMed ID: 23716054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.
    Barchiesi F; Spreghini E; Sanguinetti M; Giannini D; Manso E; Castelli P; Girmenia C
    J Antimicrob Chemother; 2013 Nov; 68(11):2587-91. PubMed ID: 23794598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.